ArticleCancer medicine2022

A novel signature based on immune-related gene pairs and clinical features to predict prognosis and treatment effect in "driver gene negative" lung adenocarcinoma.

He-Yuan Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.